A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors
Keyword(s):
Keyword(s):
2018 ◽
Vol 19
(5)
◽
pp. e619-e627
◽
Keyword(s):
Keyword(s):
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7168-7168
Keyword(s):
Keyword(s):
Keyword(s):